Discover 1,973 paid clinical trials in Miramar, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,973
A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
for
Hereditary Angioedemas
Location: Miami FL, Belleville NJ, Saint Charles IL, Phoenix AZ,
Sponsor: CSL Behring
Sex: All
Age: 12+
Code: NCT07001280
Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Location: Cutler Bay FL, Orlando FL, Altamonte Springs FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07783802
Phase 2, Recruiting
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
for
Epiretinal Membrane
Location: Springfield OR, Sarasota FL, Wesley Chapel FL,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 50+
Code: NCT05145491
Recruiting
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
for
Healthy Volunteers, Influenza
Location: Miami Lakes FL, Coral Gables FL, Fort Myers FL,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07779408
Phase 1, Phase 2, Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
for
Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer,
Location: Miami FL, Fairfax VA, East Brunswick NJ, Springdale AR,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07625644
Phase 3, Recruiting
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Miami FL, Tampa FL, Decatur GA, Birmingham AL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 18+
Code: NCT06701903
Phase 2, Recruiting
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for
Urothelial Cancer
Location: Miami FL, Nashville TN, Charlottesville VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07106762
Phase 2, Phase 3, Recruiting
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)